BASSEL AL-LAHHAM
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology PHOENIX, AZ NPI 1619081577
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology AZ BOSTON SCIENTIFIC CORPORATION All categories
General Payments — all program years on this page
$2,408.75
- Category: General Payments
- Program years: PY2018–2024
- Record count: 38
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $595.48 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $595.48 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $147.26 | 1 |
| Ipsen Biopharmaceuticals, Inc | $144.98 | 1 |
| Madrigal Pharmaceuticals | $144.22 | 1 |
| GENZYME CORPORATION | $143.97 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.05 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1091992105 | Ipsen Biopharmaceuticals, Inc | $144.98 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092669679 | Boston Scientific Corporation | $147.26 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139593388 | GENZYME CORPORATION | $14.64 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139593444 | GENZYME CORPORATION | $115.74 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139593478 | GENZYME CORPORATION | $13.59 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144159863 | Madrigal Pharmaceuticals | $144.22 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153412790 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.05 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.